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cancer screening data, all Wales injury sur-
veillance system, all Wales perinatal survey, 
congenital anomaly register and information 
service, birth and death data from the Office 
for National Statistics, and social services 
databases. The SAIL data systems also al-
lows linkage of data collected through patient 
questionnaires, which then enables following 
the patient pathway through the NHS system 
both retrospectively and prospectively from 
a reference date (e.g. questionnaire comple-
tion date). Separately a cohort of people with 
ankylosing spondylitis (AS), i.e. the Welsh 
population-based ankylosing spondylitis 
(PAS) cohort has been developed using data 
collected from 500+ patient completed ques-
tionnaires, which was then linked within the 
SAIL data systems [4].
HERALD – POTENTIAL BENEFITS 
OF USING LINKED DATA
The linkage of routine data, patient complet-
ed questionnaires and trial data offers unique 
opportunities for enhanced health economic 
analysis, including assessment of the validity, 
reliability and generalizability of health eco-
nomic data not possible through the use of 
traditional isolated datasets. In the HERALD 
paper [1] we use the PAS cohort by linking 
patient reported study datasets with the rou-
tinely collected general practitioner data; in-
patient and outpatient datasets; and Accident 
and Emergency department data in the Unit-
ed Kingdom, and outline the following po-
tential benefits of using the linked SAIL-PAS 
cohort data in the conduct of health economic 
analysis in general, and the cost of ankylos-
ing spondylitis, in particular.
Retrospective and prospective 
tracking of patient pathways
With data spanning multiple years and the 
ability to link records across several data-
CONTEXT
The major sources of data in the healthcare 
research include the data generated from ran-
domised controlled trials (RCTs), observa-
tional studies based on patient derived ques-
tionnaire data, and routinely assembled data 
abstracted from the primary and secondary 
care patient record – popularly known as rou-
tine data. Data generated from these routes 
are usually used as stand-alone datasets, and 
alongside non-health data such as demo-
graphic, socio-economic, and geographical 
data. The health sector analyses are enriched 
when the patient-level data generated from 
these different sources are linked.
In a recent paper, titled “HERALD (Health 
Economics using Routine Anonymised 
Linked Data)” [1], we demonstrate the po-
tential methodological advantages in the 
conduct of health economics analyses using 
patient-derived questionnaire data linked 
with routinely collected information and 
secondary care clinical datasets available in 
Wales, United Kingdom, with examples from 
a research cohort.
LINKED ROUTINE DATA IN 
WALES: THE SAIL DATABANK 
AND THE PAS COHORT
The Health Information Research Unit 
(HIRU) at the College of Medicine at 
Swansea University has set up the Secure 
Anonymised Information Linkage (SAIL) 
databank [2,3]. The SAIL databank brings to-
gether and links a wide range of person-based 
data anonymously. The range of complemen-
tary sets of data includes clinical data from 
rheumatologists, existing routinely collected 
datasets such as the General Practice (GP) 
records, outpatient (OP) clinical data, inpa-
tient (IP) episodes, accident and emergency 
(A&E) department, pathology data, NHS 
administrative register, breast and cervical 
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sets, it is possible using SAIL to track the 
healthcare utilisation history of patients in 
receipt of some form of intervention for a 
given condition across multiple healthcare 
sectors both before and after their index/ref-
erence healthcare event. Therefore, the SAIL 
data linkage system allows tracking of the 
patient pathways, both retrospectively and 
prospectively. Linkage with GP data system 
provides information about patients’ primary 
care events going back many years includ-
ing previous diagnoses, referrals, presenting 
symptoms, investigation results and previous 
medications. This dataset can also be used to 
follow the patient at every visit to the GP and 
therefore record the development of associ-
ated conditions and use of co-medications. 
Linkage with IP data will record all hospital 
visits, surgery and hospital treatment. Link-
age with the mortality datasets will ensure 
the dataset remains relevant and can examine 
survival of included patients. Linkage with 
A&E datasets will give information on emer-
gency visits.
Validation of patient-reported 
recall data
The use of linked routine data allows cross-
checking of patient-reported recall data with 
actual healthcare events at the personal level. 
The inherent limitations (or strengths) of the 
data quality pertaining to the survey ques-
tionnaires under the recall method can be 
flagged; and an assessment of the general-
isability of the patient-reported data can be 
made. On the other hand, data obtained from 
routinely collected data systems often require 
careful interpretation with respect to their 
quality, validity, timelines, bias, confounding 
and statistical stability [5]. With the triangu-
lation of datasets in the SAIL system, the va-
lidity and reliability of single datasets can be 
assessed [4]. The triangulation process will at 
least flag the discrepancies, and we can then 
have an idea about any quality issue pertain-
ing to both the routine and questionnaire data.
Objective measure 
of the cost of illness
The use of linked data enhances the preci-
sion of the healthcare use information and 
the timelines within which the costs incurred; 
and therefore will help provide an objective 
estimate of the cost and burden of diseases to 
the funders, health service (NHS in the Unit-
ed Kingdom), society and the individual at 
each stage of disease over a prolonged period 
of time. In many conditions there is a delay 
between the onset of symptoms and estab-
lishing a diagnosis, during which period the 
patients still utilise healthcare resources. The 
linked routine data can provide information 
about the patients’ visits to healthcare facili-
ties during this symptomatic pre-diagnosis 
period, when the requirement for diagnostic 
investigations is often greatest. For example, 
within the SAIL data system, we can identify 
patients from a cohort of any particular dis-
ease who were diagnosed during a reference 
time (as indicated by first appearance of a 
specific diagnostic read code); and link those 
with various datasets (e.g. GP data, IP hospi-
tal admissions, OP, A&E data etc.) to track 
their pre-diagnosis visits to healthcare fa-
cilities since the date the symptom onset (as 
reported by the patients or established from 
the GP or A&E records). This allows one to 
compare the extent of health service utilisa-
tion, and therefore related costs, before and 
after the symptoms developed. In addition, 
one can also calculate the costs as a result of 
delayed diagnosis. This provides a more ob-
jective estimate of the actual costs of chronic 
conditions and any interventions.
Healthcare pathways 
and referral history
A retrospective analysis of the patient’s 
healthcare history can identify the types of 
referrals to healthcare services made at dif-
ferent points in time facilitating assessment 
of health service usage and recommenda-
tions for improving patient care pathways, 
and thus maximise clinical efficiency and ef-
ficiency in the use of resources. Such analy-
sis makes it possible to deduce whether the 
anonymised individuals in question were 
suffering any common co-morbidities, in re-
ceipt of healthcare treatment prior to the oc-
currence of the reference event, whilst it also 
allows any frequent complications requiring 
medical attention in the days, months, years 
following the event (which could be an in-
tervention or questionnaire) to be identified. 
The temporal aspects of the linked data sets 
also help conducting event history analysis, 
survival analysis and other relevant statistical 
and econometric models.
Profiling of patients
The linked data includes diverse sets of infor-
mation, which enables profiling and stratifica-
tion of patients relating to disease manifesta-
tions and severity, lifestyle, co-morbidities, 
and associated costs. Additionally, given that 
many chronic conditions have heterogene-
ous manifestations with a variable course and 
unpredictable episodes of exacerbation, the 
analysis can be carried out under several per-
son stratification schemes based on severity of 
disease, various demographic attributes, and 
socio-economic conditions. This stratification 
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will facilitate early targeting of interventions 
to patients at highest risk, thereby improving 
the cost-effectiveness of these interventions.
CONCLUSION
From the methodological perspective, any 
linkage system would add new dimensions 
and perspective to traditional health related 
research (e.g. complement and enhance the 
results of RCTs), as a resource for clinical au-
dits, and in a variety of health impact assess-
ment exercises. Linked routine data provides 
many opportunities for enhanced healthcare 
research and allows evaluation of impacts be-
yond the limited primary outcomes of inter-
ventional studies. These linkable databases 
provide factual and continuous information 
with rich clinical and non-clinical details, 
which offers wide ranging opportunities in 
the realm of conducting evaluative research, 
clinical epidemiology, trial recruitment, ge-
netic research, basic research of biological 
markers, stratified medicine, post-trial sur-
veillance, risk assessment, service delivery 
evaluation, resource use, decision analysis, 
identification of early disease predictors, and 
the identification of subjects for prospective 
studies. This data system also offers the op-
portunity for post-marketing surveillance and 
pharmacovigilance of new expensive, and 
often potentially dangerous, healthcare inter-
ventions in real-life settings. Complementing 
this resource with targeted health economic 
analysis, as proposed in the HERALD meth-
odology, offers a unique opportunity to deliv-
er the level of health economic data required 
to evaluate and drive forward cost-effective 
modern healthcare services.
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